About Ethris
Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. We are using our proprietary technologies to develop a new approach for the treatment of pulmonary diseases.
Our Technology
Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technologies. Our integrated platform enables the discovery, design and development of transcript therapies.
About Ethris
Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. We are using our proprietary technologies to develop a new approach for the treatment of pulmonary diseases.
Our Technology
Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technologies. Our integrated platform enables the discovery, design and development of transcript therapies.
-
Ethris’ proprietary Stabilized Non-Immunogenic mRNA (SNIM® RNA) platform includes a toolbox of technologies to generate mRNA molecules that are stable, result in production in the patient’s own body of therapeutic proteins, and which escape recognition by the body’s immune system. These mRNA technologies paired with Ethris proprietary delivery systems for organ- and cell- targeted delivery of mRNA has generated a pipeline of Transcript Therapies, which Ethris is developing to treat serious diseases.SNIM® RNA PLATFORMREAD MORE -
Ethris’ focus is on the development of therapeutic mRNA for the treatment of metabolic and respiratory diseases. Our technology helps to replace or augment missing or non-functional proteins that cause a disease, or introduce new proteins to modulate the course of disease or symptoms.DELIVERING THE PROTEIN CONSTRUCTION PLANREAD MORE